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Head Start: Graduate Level Resources in Materials Engineering 
 
This serial publication includes technology and science topics relevant to research in materials 
engineering. It is intended to supplement discipline specific undergraduate education and also 
provide detailed information on specific processing systems. 
 
Forward 
Issue 1: Ceramics for Medical Applications, March 2008. 
 
Graduate level research has traditionally involved an initial period of intensive reading. Obvious 
resources include peer reviewed papers, conference papers and theses. However, for most students 
considerable time is also spent on technical descriptions of equipment and procedures, and on reading 
textbooks on relevant topics not covered by their own undergraduate training. The latter can be 
particularly pertinent to engineers working on a cross discipline project extensively involving materials 
chemistry or biological systems. While there is no doubt as to the value of a broad understanding of the 
context of a project, nor the need to understand relevant equipment, chemical processes and biological 
systems, this information is not generally at research level. 
 
Nonetheless it can be a very time consuming exercise to come ‘up to speed’. Add to this the wealth of 
research being made accessible through electronic databases, and the rapidly growing volume of 
research being published, and the initial phase of reading oneself into a project can be very daunting.  
 
Having observed many graduate students of the Materials Processing Research Centre at Dublin City 
University struggle through this process, I noted that we were not building effectively on this type of 
understanding gained by each student. There has also been confusion as to what is appropriately 
included in theses, with examiners taking different views on the amount of content to be dedicated to 
explaining concepts, terminology and systems from the complementary discipline. 
 
From these observations came the idea of a series of publications dedicated to giving graduate students 
a ‘head start’. These are written by graduate students, largely based on their reading of text books in 
science and engineering disciplines relevant to their project. Where it is appropriate, students have 
collaborated on a theme. It is intended that the texts consolidate existing MPRC background knowledge 
on a topic, thus providing a ‘fast track’ for new researchers to start on their own work on a related 
project. It is intended they be an open ended serial, with new students and all MPRC members being 
welcome to submit new titles.  
 
 
Lisa Looney 
Series Editor 
 
Director, Materials Processing Research Centre. 
Dublin City University 
Ireland 
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1 Biomaterials 
1.1 Introduction 
There are numerous materials that have been identified as being safe for use within the 
human body. These materials are termed biomaterials. Biomaterials have been defined as 
‘any material that is used to replace or restore function to a body tissue and is continuously or 
intermittently in contact with body fluids’ [1]. They include metals, polymers, ceramics and 
also composite materials.  
 
1.2 Properties of Biomaterials 
There are a number of important properties that a material must have in order for it to be 
suitable for use in the body. It should have a biocompatible chemical composition that does 
not induce adverse tissue reaction. This means that it should be non-toxic, non-carcinogenic, 
non-allergic and non-inflammatory. It must also be bio-functional, with sufficient strength and 
wear resistance to withstand the environment in which it is placed. Depending on the 
application for which it is used, it may also need to be able to stable over long periods, have 
specific degradation rates or encourage bone ingrowth. 
 
1.3 Types of Biomaterials 
1.3.1 Metals 
Metals are used for a wide range of medical applications. These include orthopaedic implants, 
implants, plates and screws for oral and maxillofacial surgery, components for devices used 
in cardiovascular surgery, e.g. pacemakers, valve replacements and stents [1]. Surgical and 
dental instruments are also made from metallic materials. Due to the requirements for 
biocompatibility, relatively few metals are suitable for medical applications. Those most widely 
used for structural applications are titanium, titanium alloys, cobalt-base alloys and various 
grades of stainless steel. Metals used for other applications include commercially pure 
titanium, shape memory alloys (based on the nickel-titanium binary system), zirconium alloys, 
tantalum, niobium and precious metals, such as silver. Some examples of the metals used for 
various applications are given in table 1.1. The mechanical properties of various metals used 
for medical applications are given in table 1.2.  
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Table 1.1: Some bio-metallic materials and their applications [1, 2] 
Application Metal 
Joint prostheses 
316L stainless steel, cobalt-base alloys, titanium and 
titanium alloys 
Bone screws and pins 
Austenitic stainless steel, 316L stainless steel, 
titanium alloys 
Angioplasty 
Shape-memory alloys e.g. nickel titanium alloys and 
copper-base alloys 
Pacemaker cases Commercially pure titanium alloy 
Pacemaker electrodes  
304, 316 and 316L stainless steel, cobalt alloys, 
tungsten bronzes, zirconium, tungsten, tantalum and 
titanium. 
Medical staples 
304, 316 and 316L stainless steel, nickel titanium 
alloys 
Vascular stents Nickel titanium alloys 
Dental implants Titanium and titanium alloys 
Dental crowns and bridges 
Porcelain-fused to metal (PFM) type: gold alloys, 
palladium alloys, nickel alloys, cobalt-chromium 
alloys, titanium and titanium alloys 
 
Table 1.2: Mechanical properties of metals used for implants [2] 
Material 
Young’s Modulus 
(GPa) 
Tensile strength 
(MPa) 
Fracture Toughness  
(MPam
1/2
) 
Cobalt-chromium 
alloys 
210 400-1030 120-160 
Stainless steel 
(316L) 
193 515-620 20-95 
Ti-6Al-4V 114 900-1172 44-66 
 
3 
1.3.2 Polymers 
Polymers are long chain molecules derived from many repeating units called monomers [3]. 
They are typically classified into three groups, thermoplastics, thermosets and elastomers. 
Although all three groups are used for medical applications, thermoplastics are most widely 
used [1]. Some of the polymers most commonly used for medical applications include 
silicone, nylon, ultra high molecular weight polyethylene, PVC and polyurethane. They are 
used for a wide range of applications for example replacement joint components, implants, 
such as facial and breast implants, heart valves, lenses, sutures, cements and adhesives. 
Some of these applications are detailed below in table 1.3. 
 
Table 1.3: Some polymers and their applications (Adapted from [1]) 
Application Polymer 
Knee, hip, shoulder joints Ultrahigh molecular weight polyethylene 
Finger joints  Silicone 
Sutures Polylactic and polyglycolic acid, nylon 
Tracheal tubes Silicone, acrylic, nylon 
Heart pacemaker Acetal, polyethylene, polyurethane 
Blood vessels Polyester, polytetrafluoroethylene, PVC 
Gastrointestinal segments Nylon, PVC, silicones 
Facial prosthesis Polydimethyl siloxane, polyurethane, PVC 
Contact lenses Hydrogels 
Bone cement Polymethyl methacrylate 
 
1.3.3 Ceramics 
Ceramics have been used for a long time in the medical industry. They have mainly been 
used for dental and orthopaedic applications. This is due to the chemical similarity between 
the composition of certain ceramic materials and that of tissues such as bone and teeth. 
Examples of the applications of various bioceramics are given in table 1.4. The types of 
bioceramics that are currently used are discussed further in the following chapters. 
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Table 1.4: Some bioceramics and their applications (Adapted from [1]) 
Application Ceramic 
Joint replacements alumina, zirconia 
Artificial tendons and ligaments poly(lactic acid) (PLA)-carbon-fibre composites 
Dental Implants alumina, hydroxyapatite, surface-active glasses 
Coatings for chemical bonding hydroxyapatite, surface-active glasses 
Bone filler alumina 
 
1.3.4 Composites 
A composite material is a physical mixture of two or more distinct constituents [4]. There is no 
chemical bonding or alloying between the constituents. Composite materials have properties 
very different to the properties of their constituents. By adjusting the proportions of the 
constituent materials used, the materials properties of the composite can be tailored for the 
specific application. In general a composite just consist of two constituents, a matrix phase, 
which forms the bulk of the material, and a reinforcing phase, which generally provides 
strength. For some applications bioactive particles, which encourage bone growth, are used 
as the reinforcing phase. Composite materials are widely used in medical applications. Some 
examples of composite materials used for various applications are given in table 1.5.  
 
Table 1.5: Some biocomposites and their applications  
Application Composite 
Dental restoration 
BIS-GMA (a resin monomer) reinforced with quartz, 
barium glass or colloidal fillers 
Bone plates 
polymer composites e.g. carbon fibre (CF)/epoxy, 
glass fibre (GF)/epoxy 
Vascular grafts 
pellathane-type polyurethane matrix with Lycra-type 
polyurethane fibres 
Total hip replacements CF/ polystyrene (PS), CF/ carbon (C) 
Bone grafts 
polymers e.g. PLLA, PEG, gelatine,  reinforced with 
bioactive particles 
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2 Bioceramics 
2.1 Introduction 
Ceramics are compounds between metallic and non-metallic elements; most frequently 
oxides, nitrides and carbides [5]. Ceramics tend to have a low energy state, which means that 
they tend to be stable and may well be considered the most chemically and biologically inert 
of all materials. The wide range of materials that falls within this classification includes 
ceramics that are composed of clay materials, cement and glass [6]. Unlike metals and 
polymers, ceramics are difficult to shear plastically due to the nature of the ionic and covalent 
bonding holding them together and also the minimum number of slip systems [7].  
 
Ceramics in the form of pottery have been used by humans for thousands of years. In the 
past properties such as their inherent brittleness, susceptibility to notches or microcracks, low 
tensile strength and low impact strength has limited their use. However, within the last 100 
years, improvements in the techniques used for the fabrication of ceramics have lead to their 
use as ‘high tech’ materials [5]. 
 
More recently it has been recognised that the characteristic properties of hardness, durability 
and chemical resistance displayed by ceramics mean that many can withstand the hostile 
environment within the body. Over the past forty years ceramics have been specifically 
designed for the repair and reconstruction of diseased and worn out body parts. These 
ceramics are termed ‘bioceramics’ [8]. They are now used for many important applications in 
the body as outlined in table 1.4. 
 
2.2 Classification of Bioceramics 
No foreign material that is implanted into living tissue can be completely compatible. Any 
material that is recognized as foreign elicits some form of response from living tissue. 
Bioceramics can be classified according to the response that they initiate within the body. 
There are three main classes; virtually inert, bioactive and resorbable bioceramics. Examples 
of materials that fall into each of these classifications are given in table 2.1.  
2.2.1 Virtually Inert Ceramics 
Virtually inert ceramics have minimal interaction with their surrounding tissue. They therefore 
maintain their physical and mechanical properties while in the body and are also resistant to 
corrosion and wear. Examples include aluminium oxides, zirconia ceramics and single phase 
calcium aluminates. Virtually inert ceramics may be used for structural support, such as bone 
plates, bone screws and femoral heads, and also non-structural support, such as drug 
delivery devices and ventilation tubes. 
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Table 2.1: Classification of Bioceramics [8, 9] 
Type of 
Bioceramic 
Interaction with tissue 
Type of 
Attachment 
Example 
Virtually Inert 
Little or no biological 
response 
Mechanical 
fixation 
alumina (Al2O3), zirconia oxide 
(ZrO2) 
Bioactive 
Promote a distinct and 
positive response from 
tissue 
Chemical 
bonding 
hydroxyapatite (HA), bio-active 
glasses and glass-ceramics 
Resorbable 
Gradually dissolve within 
the body 
Replaced by 
tissue 
calcium phosphate cements, 
bio-active glasses and 
tricalcium phosphate 
 
2.2.2 Bioactive Ceramics 
Bioactive ceramics or surface-reactive ceramics undergo chemical reactions at their surface. 
They thereby allow the formation of a chemical bond between the implant and the tissue. The 
type of interface that forms mimics the type of interface that is formed when natural tissues 
repair themselves [8]. Examples of bioactive ceramics include glasses, such as the 
commercially available glass Bioglass®, and calcium phosphate ceramics such as 
hydroxyapatite. Bioactive ceramics have many applications including coatings for metal 
prosthesis, in reconstruction of dental defects, as replacements for middle ear ossicles, as 
bone plates and screws and for filling spaces vacated by bone screws, donor bone, excised 
tumours and diseased bone loss.  
 
2.2.3 Resorbable Bioceramics 
Resorbable implants gradually dissolve when placed into the body and are replaced by 
natural tissues. In order for the implant to be successful the dissolution rate must match the 
repair rates of the body tissue [10]. Dissolution rate depends on the composition and structure 
of the material. The concept of using synthetic resorbable ceramics as bone substitutes was 
introduced by Hentrich in 1971 [11]. Examples of bioresorbable materials include porous 
calcium phosphates, such as tricalcium phosphate, bioglass, zinc-calcium-phosphorous oxide 
(ZCAP) ceramics, zinc-sulphate-calcium-phosphate (ZSCAP) ceramics, aluminium-calcium-
phosphate (ALCAP) ceramics and ferric-calcium-phosphorous-oxide (FECAP) ceramics.  
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2.3 Compositional Classification of Bioceramics  
Bioceramics can be classified according to their compositions. The major groups are oxide 
ceramics, glasses and calcium phosphate bioceramics.  
 
2.3.1 Oxide Ceramics 
The major types of oxide ceramics are alumina (Al2O3)-based ceramics and zirconia (ZrO2)-
based ceramics. Other simple oxides that have been investigated for use in biomedical 
applications include CaO.Al2O3, CaO.TiO2 and CaO.ZrO2.  
 
Alumina (Al2O3)-based ceramics 
Alumina ceramics are reportedly the first bioceramics to be widely used clinically [12]. They 
have many favourable characteristics including good strength, high wear resistance, good 
biocompatibility and excellent corrosion resistance. They have good hardness with values 
ranging from 20 to 30GPa [7]. Both single and polycrystalline alumina have been used 
clinically. The most stable phase is α-Al2O3. MgO, CaO and Y2O3 have been added to 
alumina in low percentages to control its granular growth, and consequently the densification 
[13].  
 
Because of its high wear resistance, alumina is currently used for the bearing surfaces in joint 
replacements. It is also used for other applications, such as porous coatings for femoral 
stems, porous bone spacers, middle ear implants and for dental implants.  
Zirconia-based ceramics 
Zirconia-based ceramics have become a popular alternative to alumina as a structural 
ceramic because of their substantially higher fracture toughness [12]. They have better 
reliability, a higher flexural strength and a lower Young’s modulus than alumina and can also 
be polished to a superior surface finish. Zirconia-based ceramics also have excellent 
biocompatibility and, although they are not quite as hard as alumina, they have excellent wear 
and friction resistance. One disadvantage of these ceramics is the fact that zirconia 
undergoes a volume change of about 5% during phase changes at high temperature, which 
can cause fracture. Zirconia is therefore generally stabilized with a dopant, such as yttria 
(Y2O3) or magnesium oxide (MgO), which promotes the formation of a more stable cubic 
phase [13, 14]. Zirconia-based ceramics produced with the use of a stabiliser is referred to as 
partially stabilised zirconia [7]. Partially stabilized zirconia is used for the bearing surfaces in 
joint replacements. Oxidized zirconia has also recently been introduced for this application. 
Zirconia dental implants have also been produced although they are not widely used.  
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2.3.2 Carbons 
The biocompatibility of carbon has long been recognized. It is available in numerous different 
forms. These include pyrolitic carbon, crystalline diamond, graphite, noncrystalline glassy 
carbon and carbon fibres. Some carbons have been found to have excellent thrombo-
resistance properties and are used for applications such as artificial heart valves and 
pacemaker electrodes. The main types used for this application are low temperature isotropic 
(LTI) pyrolytic carbon, vitreous (glassy) carbon and ultra-low temperature isotropic (ULTI) 
carbon [9]. The composition, structure and fabrication of these three carbons are similar to 
those of graphite and other industrial forms produced from pure elemental carbon [1].  
 
Other carbons that are used in the medical industry include diamond-like carbons and carbon 
fibres. Diamonds-like carbons have high hardness, wear resistance, optical transparency, 
chemical inertness, low friction and good adhesion properties [15]. They have been found to 
have excellent biocompatibility. Their use as a protective coating for implants, produced using 
vapour deposited methods, has been investigated. These coatings have produced good 
results but they are difficult and costly to manufacture. 
 
High strength carbon fibres were developed in the 1950’s for the aerospace industry [16]. 
They have since found application in numerous other areas including the biomedical industry. 
They have high strength and a high modulus of above 50 million PSI. These fibres can be 
incorporated into other materials to form a high stiffness structure. Carbon fibres can be 
formed in many ways. The final properties depend on the processing technique used. They 
are used for applications such as bone plates, implants and artificial tendons and ligaments.  
 
2.3.3 Glasses 
It was discovered by Hench et al. in 1969 that bone can bond chemically to certain glass 
compositions [17]. The main glasses used for implantation are SiO2-CaO-Na2O-P2O5 and 
Li2O-ZnO-SiO2 systems [7]. Many glasses are based on a formula called 45S5, signifying 45 
wt% SiO2 and 5 to 1 molar ratios of CaO and P2O5  [1]. Glasses with lower molar ratios of 
CaO to P2O5 do not bond to bone. The most reactive glass compositions have been shown to 
develop a stable, bonded interface with soft tissues.  
 
It is possible to design glasses with properties specific to a particular clinical application [17]. 
The main advantage of bioactive glasses is the rapid tissue bonding they induce. The primary 
disadvantage is mechanical weakness and low fracture toughness due to their amorphous 
two-dimensional glass network [17]. Two commercially available bioactive glasses are 
Cervital® and Bioglass®. 
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2.3.4 Calcium Phosphate Ceramics 
Calcium phosphate can be crystallized into various calcium phosphate ceramics depending 
on the Ca:P ratio, presence of water, impurities and temperature [7]. Examples of phases 
formed include tri-calcium phosphate, tetracalcium phosphate and hydroxyapatite. Calcium 
phosphate ceramics have received a lot of research attention due to their chemical similarity 
to calcified tissue (bones, teeth). They have been used in dentistry and medicine for about 
thirty years. 
 
Table 2.2: Some Calcium Phosphate Compounds [13, 18] 
Chemical Definition Symbol Phase Chemical Formula 
Ca/P 
Ratio 
Monocalcium 
phosphate hydrate 
MCP  Ca(H2PO4)2 0.50 
Dicalcium phosphate 
anhydrous 
DCPA Monetite CaHPO4 1.00 
Dicalcium phosphate 
dihydrate  
DCPD Brushite CaHPO4.2H2O 1.00 
Octocalcium 
phosphate 
OCP  Ca8H2 (PO4)6.5H2O 1.33 
α-Tricalcium phosphate α-TCP  α-Ca3(PO4)2 1.50 
β-Tricalcium phosphate β-TCP Whitlockite β-Ca3(PO4)2 1.50 
Tetracalcium 
phosphate 
TTCP Hilgenstockite Ca4(PO4)2O 2.00 
Oxyhydroxyapatite OHA  
Ca10(PO4)6(OH)2-2x 
(O4)(  ٱ )x 
 
Oxyapatite OXA  Ca10(PO4)6O 1.67 
Hydroxyapatite HA  Ca10(PO4)6(OH)2 1.67 
Amorphous calcium 
phosphate 
ACP  N/A  
 
Calcium phosphate ceramics can be used in block form for applications such as spinal fusion 
and bone space filling, for example after the removal of a tumour. They can also be used in 
granule form to help repair damaged bone in procedures such as alveolar ridge augmentation 
and maxillofacial surgery. In loading bearing applications their inherent brittleness requires 
them to be used as a coating material on a tougher substrate. These coatings are used to 
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encourage the ingrowth of bone material and are used for the fixation of dental implants and 
joint replacement components. More recently they have shown potential for use as 
percutaneous implants and as drug release ceramics. Calcium phosphate can also be used 
for calcium phosphate cements (CPC). There are two types, apatite CPC and brushite CPC. 
Different calcium phosphate compounds along with their chemical composition and Ca/P ratio 
are summarised in table 2.2. 
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3 Hydroxyapatite 
3.1 Introduction 
Hydroxyapatite (HA), as discussed above, is a calcium phosphate bioceramic. The similarity 
between these calcium phosphate bioceramics and the mineral component of bone is 
reported to have been first recognised in 1788 by Proust and by Klaprota [19]. This similarity 
lead to the development of many commercial and non-commercial calcium phosphate 
materials, including ceramic HA, non-ceramic HA, coralline HA, β-TCP, and biphasic calcium 
phosphates. The first successful repair of a bony defect with a calcium phosphate reagent, 
described as triple calcium phosphate compound, was reported by Albee in 1920 [20].  
 
In the late sixties and early seventies other researchers, such as Levitt and Monroe, 
developed methods for the production of ceramic materials for use in dental and medical 
applications [21].  In the mid-seventies Jarcho et al. in the USA, deGroot et al. and Denissen 
in Europe, and Aoki et al. in Japan began to work simultaneously but independently towards 
the development and commercialization of hydroxyapatite [21].  
 
Hydroxyapatite is now used in many orthopaedic applications. It has been used to form 
spacers in several shapes e.g. as an iliac bone spacer inserted into the defected iliac bone 
after an iliac bone is removed as an autobone graft [22]. HA can be filled into bone defects 
resulting from the removal of bone tumours. It can be used on its own or mixed with autograft 
bone chips. HA coatings and HA composite coatings can be used as coatings on hip and 
knee replacements. HA is also used in bioactive bone cements. 
 
3.2 Chemical Structure  
Hydroxyapatite crystallizes to form a hexagonal structure and because of this structure is 
recognised as belonging to the ‘apatite’ family. Compounds in this family all have a similar 
hexagonal structure but have different compositions. Apatite was first named as a mineral by 
Werner in 1786 [19]. The name was derived from the Greek word “to deceive”, [19], because 
it had been confused with several other minerals of similar appearance including beryl, 
amethyst, olivine and fluorite. Calcium apatites have the general chemical formula 
Ca5(PO4)3X, where X is an electronegative element or group such as halogen or an OH group 
[23]. As shown in table 2.2 HA has the formula Ca10(PO4)3(OH)2 and a Ca/P ratio of 1.67. 
Other examples of calcium apatites include fluorapatite (FA), Ca5(PO4)3F and chlorapatite 
(CA), Ca5(PO4)3Cl.  
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The structure of calcium HA is reported to have been determined by Beevers and McIntyre 
and later refined by Kay et al. [21]. The unit cell contains Ca, PO4 and OH ions closely packed 
together to represent the apatite structure. Most researchers suggest that hydroxyapatite has 
a hexagonal crystal structure with a space group, P63/m [21, 24]. The unit cell for this 
structure can be seen in figure 3.1. This space group is characterised by a six-fold c-axis 
perpendicular to three equivalent a-axes (a1,a2,a3) at angles of 120º to each other. The ten 
calcium atoms belong to either Ca(I) or Ca(II) subsets depending on their environment. Four 
calcium atoms occupy the Ca(I) positions: two at levels z = 0 and two at z = 0.5. Six calcium 
atoms occupy the Ca(II) positions: one group of three calcium atoms describing a triangle 
located at z = 0.25, the other group of three at z = 0.75, respectively. The six phosphate (PO4) 
tetrahedral are in a helical arrangement from levels z = 0.25 to z = 0.75. The network of PO4 
groups provides the skeletal framework which gives the apatite structure its stability. The 
oxygens of the phosphate groups are described as one OI, one OII and two OIII [21]. The 
dimensions of the unit cell at room temperature are: a0 = b0 = 9.11Å and c0 = 6.86 Å [23].  
 
 
Figure 3.1: Hydroxyapatite Unit Cell [25] 
 
However, this structure is usually associated with non-stoichiometric HA containing impurities. 
A hexagonal P63 structure has been suggested for stoichiometric HA [26].This structure gives 
a poor least squares fit to XRD diffraction and thus its acceptance is limited. Two monoclinic 
models have also been suggested, P21/b [27] and P21 [28]. These have been found to give a 
better fit to diffraction patterns and also to be more energetically favourable models of the 
structure of HA [28]. The calculated density of hydroxyapatite is 3.219 g/cm
3 
[7]. 
 
3.3 Substitutions 
The apatite structure is a very hospitable one, allowing the substitutions of many other ions. 
Substitutions can occur for the (Ca), (PO4) or (OH) groups. These substitutions result in 
changes in the properties of the crystal including changes in lattice parameters, morphology 
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and solubility. Differences in lattice parameters between substituted and unsubstituted HA 
reflect the size and the amount of the substituting ions. The possible substitutions for each 
group are shown in table 3.1. 
 
Table 3.1: Possible Substitutions in the apatite structure 
Ca10 (PO4)6 (OH)2 
Sr
2+
 Na
+
 AsO4
3-
 CO3
2-
 F S
2-
 
Pb
2+
 Ln
3+
 VO4
3-
 CO3F
3-
 Cl O
2-
 
Cd
2+
  SiO4
4-
  Br O
2
 
Mn
2+
  SO4
2-
  I H2O 
Mg
2+
  HPO4
2-
  CO3
2-
  
 
Cl substitution causes the loss of hexagonal symmetry but exhibits monoclinic symmetry, 
because of the alternating positions of the Cl atoms, and causes an enlargement of the cell in 
the b direction. Substitution of F for OH, causes a contraction in the a-axis dimension without 
changing the c-axis [7]. This is because symmetrically shaped fluoride allows closer 
coordination with the nearest calcium than asymmetric hydroxyl, with its two atoms, does [7]. 
This substitution generally causes an increase in the crystallinity leading to greater stability of 
the structure [21]. This increased stability is reflected in the observation that F-substituted 
apatites are less soluble than F-free synthetic and biological apatites.  
 
Carbonate, CO3, can substitute either for the hydroxyl (OH), Type A substitutions, or the 
phosphate (PO4) groups, Type B substitutions [21]. These two types of substitutions have 
opposite effects on the lattice parameters, a-axis and c-axis dimensions.  In the case of Type 
A, the substitution of larger planar CO3 group for smaller linear OH group, causes an 
expansion in the a-axis and contraction in the c-axis dimensions. For the Type B, the 
substitution of smaller planar CO3 group for a larger tetrahedral PO4 group causes a 
contraction in the a-axis and expansion in the c-axis dimensions. Coupled CO3 for PO4 and 
Na for Ca substitutions cause changes in the size and shape of the apatite crystal: from 
acicular crystals to rods to equi-axed crystals with increasing carbonate content and 
dissolution properties: the CO3 substituted apatite being more soluble than CO3–free synthetic 
apatites [21]. Other ions which may substitute for calcium in the apatite structure include 
strontium (Sr) and magnesium (Mg). The substitution of Sr for Ca or Mg for Ca causes an 
increase in the extent of dissolution of the apatite.  
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3.4 Biological Calcium Phosphate 
In biological systems, apatite or apatitic calcium phosphates occur as the principal inorganic 
constituent of bone and tooth. They comprise approximately 70 wt% of natural bone [29]. 
They also occur as the major crystalline components in pathological calcification such as 
dental and urinary calculi and stones [30]. 
  
Biological apatites have a similar composition and crystallinity to HA. They contain many 
impurities and are typically calcium deficient and carbonate substituted. The Ca/P ratio of 
biological apaite can be as low as 1.50. The stoichiometry of HA varies with its location in the 
body and also is known to increase with age [30]. It has been proposed that the 
crystallographically disorder of biological apatites is caused by this carbonate substitution into 
the apatite lattice [31]. The non-stoichiometry of biological apatites led to speculations that 
they could form from precursor phases such as amorphous calcium phosphate (ACP) or 
octocalcium phosphate (OCP), which may initially form and then hydrolyze to apatite. To date 
the exact structure of biological apatites remains undefined.  
 
The minor elements associated with biological apatites are magnesium, (Mg
2+
), carbonate, 
(CO3
2-
), sodium, (Na
+
), chloride, (Cl
-
), potassium (K
+
), fluoride (F
-
), and acid phosphate, 
(HPO4
2-
). Trace elements include strontium, (Sr
2+
), barium, (Ba
2+
), and lead, (Pb
2+
). Some of 
these minor and trace elements may be surface rather than lattice-bound. Lattice bound 
elements will contribute to changes in lattice parameters. Surface elements do not affect 
lattice parameters, but do contribute to changes in the crystal properties [21]. Minor elements 
such as magnesium and carbonate have been shown to cause a decrease in crystallinity and 
an increase in the extent of dissolution of synthetic apatites [21]. The main constituents of 
bone and HA are compared in table 3.2.  
 
Table 3.2: Comparison of bone and hydroxyapatite ceramics (Adapted from [9]) 
Constituents (wt%) Bone HA 
Ca 24.5 39.6 
P 11.5 18.5 
Ca/P ratio 1.65 1.67 
Na 0.7 Trace 
K 0.03 Trace 
Mg 0.55 Trace 
CO3
2-
 5.8 - 
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3.5 Biocompatibility 
The biocompatibility of synthetic HA is not only suggested by its composition but also by 
results of in vivo implantation. It has been shown to produce no local or systemic toxicity, no 
inflammation, and no foreign body response [32]. Examples of such studies are those 
completed by Ducheyne et al., [33], Ducheyne and Qiu, [34] and Buma et al. [35].  
 
3.6 Dissolution properties 
The rate of in vitro dissolution of HA depends on the composition and crystallinity of the HA. 
Factors such as the Ca/P ratio, impurities like F
-
 or Mg
2+
, the degree of micro- and macro- 
porosities, defect structure and the amount and type of other phases all have significant 
affects on biodegradation. The rate of dissolution is also dependent on the type and 
concentration of the surrounding solution, the pH of the solution, the degree of saturation of 
the solution, the solid/solution ratio and the length of time for which it is suspended in the 
solutions.  
 
Only two calcium phosphate materials are stable at room temperature when in contact with 
aqueous solutions. The pH of the solution determines which one is stable. At a pH lower than 
4.2, dicalcium phosphate (DCP) is the most stable, while at higher pH, greater than 4.2, 
hydroxyapatite (HA) is the stable phase [32, 36]. The solubility of various calcium phosphates 
in an aqueous solution is shown in figure 3.2 below. Solubility is given in terms of the calcium 
content present in the solution and varies depending on the pH of the solution.  
 
The mechanism of degradation of calcium phosphate in the body is unclear. Some 
researchers believe that cellular interaction has little effect on the dissolution kinetics. Others 
believe that the process is a physio-chemical one, in which particles are ingested by 
osteoclast-like cells attached to the surface and that intracellular dissolution of these particles 
occurs [37]. The dissolution process is known to be initiated at dislocations and grain 
boundaries. Incoherent grain boundaries, without lattice continuity, are more sensitive to 
dissolution than semi-coherent grain boundaries [38]. 
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Figure 3.2: Solubility Isotherms of various calcium phosphate phases [39] 
 
Unstable phases may interact with body fluids at 37ºC and reprecipitate as hydroxyapatite on 
the implant surface. In these conditions HA forms by the following reactions: 
 
4Ca3(PO4)2 + 2H2O → Ca10(PO4)6(OH) + 2Ca
2+
 + 2HPO4
-
   [36, 40] 
 
or 
 
3Ca4P2O9 + 3H2O → Ca10(PO4)6(OH)2 + 2Ca
2+
 + 4OH
-
    [40] 
 
Variations in the material properties of calcium-phosphate coatings affect the bone bonding 
mechanism and the rate of bone formation. Local supersaturation in the constituent ions of 
the bone mineral phase, arising from enhanced solid-solution exchange at the coating 
surface, could be a cause of bone tissue growth enhancement [32].   
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3.7 Thermal Behaviour 
3.7.1 Introduction 
The thermal properties of HA powders are important as various high temperature methods 
are used in the production of HA components and HA coatings, for example, sintering and 
plasma spraying. During plasma spraying, the temperatures reached within the plasma flame 
can be as high as 16,600°C [41]. This will depend on the gases used as well as the spraying 
parameters selected. When the hydroxyapatite powder particles experience these high 
temperatures thermal decomposition occurs, changing the balance of HA phases. This leads 
to HA coatings with significantly different crystal structure, phase composition and 
morphology than the original starting powder. The changes occurring need to be understood 
so as to ensure that the coating produced has the required composition.  
 
3.7.2 Processes Involved in the Thermal Decomposition of HA 
It is widely accepted that the heating of HA leads to three processes, 1) evaporation of water, 
2) dehydroxylation, and 3) decomposition.  
 
Evaporation of water 
Hydroxyapatite contains two types of water in its structure, absorbed water, both on the 
surface of the powder, and lattice water which exists within the lattice structure of the powder. 
When HA is heated at low temperatures the first change to occur is that absorbed water 
begins to evaporate. As the temperature is increased the lattice water then starts to 
evaporate. This has been reported by Sridhar et al. [42] to cause a contraction in the a-lattice 
dimension of the crystal structure.  
 
Dehydroxylation 
At higher temperatures, dehydroxylation occurs where hydroxyapatite gradually looses its 
hydroxyl (OH
-
) group. The dehydroxylation reaction, which has been reported by many 
authors, [42, 43] is as follows: 
 
Ca10(PO4)6(OH)2 → Ca10(PO4)6(OH)2-2xOx Vx + xH2O 
 
Where V is vacancy and x < 1 
 
If heating is carried out in an atmosphere free of water, H2O is eliminated as it forms. This 
favours the formation of a hydroxyl ion deficient product, known as oxyhydroxyapatite (OHA). 
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OHA has a large number of vacancies in its structure, a bivalent oxygen ion and a vacancy 
substitute for two monovalent OH
-
 ions of HA [42]. The weight loss due to dehydroxylation of 
HA can be calculated theoretically to be ~1.8% [44]. If heating is carried out in a moist 
atmosphere stabilised HA results [45].  
 
Decomposition 
For temperatures below a certain critical point, HA retains its crystal structure during 
dehydroxylation and rehydrates on cooling. However, once the critical point is exceeded, 
complete and irreversible dehydroxylation results. This process is called decomposition. 
Decomposition of HA leads to the formation of other calcium phosphate phases, such as β-tri-
calcium phosphate (β-TCP) and tetra-calcium phosphate (TTCP). The reaction involved in 
decomposition has been reported by Lazic et al. [46] and Sridhar et al. [42] to be as follows: 
 
Ca10(PO4)6(OH)2 → 2Ca3(PO4)2 (β) + Ca4P2O9 + H20 
 
At higher temperatures β-tri-calcium phosphate is transformed to α-tri-calcium phosphate.  
 
Temperature Effects on HA 
Although there is agreement between researchers about the processes which occur during 
the thermal decomposition of HA, it is difficult to predict the exact temperatures at which these 
reactions occur. This is because the reactions do not occur instantly but over a wide 
temperature range, which depends on a number of factors relating to both the environment 
and the composition of the HA in question. Researchers have used several techniques, such 
as thermogravimetric analysis (TGA) [44, 46], Differential Thermal Analysis (DTA) [47, 48], X-
ray Diffraction (XRD) [49], and Fourier Transform Infrared Spectroscopy (FTIR) [49], in order 
to determine the effects of temperature on HA.   
 
The evaporation of water from hydroxyapatite has been reported to occur within a wide 
temperature range, between about 25°C and 600°C [42, 44, 46, 47]. The total weight loss of 
absorbed water is reported to be as high as 6.5wt % [46]. A process called decarbonation has 
been observed by some researchers [44, 47]. The process involves the decomposition of 
carbon. Carbon may not necessarily present in the crystals originally but may be introduced 
due to handling or storage. Park et al. [47] reported that decarbonation occurs between 
600°C and 700°C and Tampieri et al. [44] noted this decarbonation process at 800°C. 
Dehydroxylation has been reported by Sridhar et al. [42] to occur between about 850°C and 
900°C. 
 
The decomposition of HA has been reported by Sridhar et al. [42] to occur from 1050°C 
onwards. Tampieri et al. [44] found that decomposition began to occur from 1200°C. Liao et 
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al. [49] found that HA was stable from 1000°C -1350°C. The highest thermal stability which 
has been found in the literature is that reported by Deram et al. [48]. The HA powder samples 
in this study were found not to show any phase transformation up to a temperature of 1450°C.  
 
The decomposition of HA into, β-TCP, TTCP and α-TCP has been reported to begin at 
1050°C by Sridhar et al. [42], 1200°C by Tampieri et al. [44] and 1400°C by Liao et al. [49]. 
Tampieri et al. [44] reported the partial melting of HA at 1550°C. Melting temperatures were 
reported by Fazan [50] to be 1550°C for HA, 1630°C for TeCP and 1730°C for TCP.  
 
Liao et al. [49] investigated the reformation of HA during cooling. It was found that when 
cooling from 1500°C at 10°C/min there was no phase transformation until a temperature of 
1350°C. Characteristic peaks of the reconstruction of HA appeared in the XRD pattern at 
1300°C, the intensity gradually increasing with the temperature decrease. The temperature 
ranges in which reactions occur as HA is heated from room temperature to 1730°C are 
summarised in table 3.3. 
 
Table 3.3: Thermal effects on Hydroxyapatite 
Temperature  Reactions  
25-600°C Evaporation of water 
600-800°C Decarbonation 
800-900°C 
Dehydroxylation of HA  forming partially or completely 
dehydroxylated oxyhydroxyapatite (OHA)     
1050-1400°C HA decomposes to form β-TCP and TTCP    
< 1120°C β-TCP is stable 
1120-1470°C β-TCP is converted to α-TCP 
1550°C Melting temperature of HA 
1630°C Melting temperature of TTCP, leaving behind CaO 
1730°C Melting of TCP 
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3.7.3 Effect of Crystal Structure and Atmospheric Conditions 
The stoichiometry of the HA powder and the partial pressure of water in the surrounding 
atmosphere have been found to have the greatest effect on the phases formed when HA 
powder is heated. The consequences of changing these factors have been investigated by 
numerous researchers.  
 
The effect of stoichiometry on the thermal stability of HA was shown by Fang et al. [51] from 
experiments in which HA powder samples with Ca/P ratios being 1.52 to 1.67 or 1.68 were 
heated to 1100°C. The results show that powder with a Ca/P ratio of 1.52 decomposed to 
TCP, powder with a Ca/P ratio of 1.67 decomposed to TCP and HA, and no decomposition 
for powder with a Ca/P ratio of 1.68. This clearly illustrates that the stoichiometry is one of the 
key factors that controls the thermal stability of HA. Tampieri et al. [44] also showed that 
stoichiometric HA seems to endure thermal treatments at significantly higher temperatures in 
respect to non-stoichiometric one.  
 
The decomposition of HA also depends on the partial pressure of water (PH20) in the 
surrounding atmosphere. Park et al. [47] report that HA is stable up 1400°C in air or 
decomposes at 1550°C at PH20 = 50mmHg. Sridhar et al. [42] found that if performed in a 
vacuum, HA loses its OH
-
 at a lower temperature, about 850°C, whereas if HA is heated in a 
H2O stream, its structure is then preserved up to 1100°C. 
 
The phase diagrams shown in figure 3.3 and figure 3.4 describe the thermal behaviour of 
CaO-P2O5 system at high temperatures in environments both with and without the presence 
of water vapour. Figure 3.3 shows the system when no water vapour is present. It can be 
seen from the diagram that hydroxyapatite is not stable under these conditions but various 
other calcium phosphates are, including tetracalcium phosphate (C4P), α-tricalcium 
phosphate (α-C3P) and mixtures of calcium oxide (CaO) and C4P.  
 
Figure 3.4 shows the system at a partial water pressure of 500mmHg. Under these conditions 
HA is found to be stable up to a maximum temperature of 1550°C. If the Ca/P ratio is not 
exactly equal to 10/6, other calcium phosphates are stable at this temperature, such as CaO 
or C4P. Figures 3.3 and 3.4 illustrate the importance of both partial water pressure and Ca/P 
ratio in the determination of the stable phases.  
 
Figure 3.5 shows more clearly the effect of partial water pressure on the CaO - P2O5 system. 
For a Ca/P ratio higher than 10/6, at temperature of 1300°C, the stable phase is αC3P + C4P if 
the partial water pressure is 1mmHg. At 10mmHg the stable phases are HA + C4P and at 
100mmHg mixtures of HA + CaO are stable.  
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Figure 3.3: Phase diagram of the system CaO-P2O5 at high temperature. No water 
present [32] 
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Figure 3.4: Phase diagram of the system CaO-P2O5 at high temperature; at a partial 
water pressure of 500mmHg [32] 
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It can be concluded that in order to avoid the dehydroxylation and decomposition of HA during 
plasma spraying a highly stable, crystalline, stoichiometric HA powder should be used. The 
environmental conditions need to be carefully controlled. Ideally, processing should be carried 
out in a moist atmosphere. This could involve a moist atmosphere during the actual spraying 
process or a moist sintering technique after spraying.  
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Figure 3.5: Influence of ambient water vapour pressure on phase composition [32] 
 
3.8 Mechanical Properties  
The mechanical properties of calcium phosphates vary considerably depending on the 
methods used in their manufacture [7]. A comparison of the mechanical properties of HA and 
bone is shown in table 3.4. 
 
Table 3.4: Mechanical Properties of HA and Bone (Adapted from [2]) 
Properties Cortical Bone Cancellous Bone HA Scaffolds 
Compressive Strength (MPa) 8-164 23 350-450 
Tensile Strength (MPa) 82-114 10-20 38-48 
Young’s Modulus (GPa) 3.8-11.7 0.2-0.5 7-13 
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The difference in preparation methods of the HA scaffold materials causes difference in grain 
size and in composition. Small grain size tends to give greater fracture toughness. Both the 
tensile and compressive strength of hydroxyapatite depend on the total volume of pores 
present. These pores can be calcified as either micropores, with diameters of about 1μm, or 
macropores, having diameters of several hundred microns [40]. HA can withstand high 
compressive force, but is weak in tension, and thus fatigue failure may occur when subjected 
to tensile or torsional forces.   
 
The resistance of a material to fatigue failure can be described in terms of the Weibull factor, 
n. Values of 50 to 100 are usually associated with good resistance [40]. The Weibull factor for 
pure HA was found to be 50 in a dry environment and 12 in a wet physiological environment 
[50]. Materials that have values between 10 and 20, are susceptible to slow crack growth 
which produces degradation in properties. 
 
Thus, despite its excellent biocompatibility and osteoconductivity, HA is unsuitable for use in 
load bearing applications such as the complex physiological loading conditions which occur at 
the hip joint. It is for this reason that HA is applied as a coating to a substrate, such as a metal 
alloy, which can provide higher strength and fatigue resistance.  
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4 Production of Hydroxyapatite Powders 
4.1 Introduction 
The first synthesis of apatite was that of Daubrée in 1851 who obtained HA by passing 
phosphorus trichloride vapour over red hot lime [52]. Since then, a number of methods of HA 
preparation have been reported. They can be divided into three main classes: 
 
1) Wet chemical methods  
 
2) Solid state reaction methods  
 
3) Hydrothermal methods 
 
4.2 Wet chemical methods 
The wet chemical method is commonly used for the production of HA as it is relatively easy to 
conduct. There are two wet chemical routes, hydrolysis and precipitation. These are 
explained below. 
 
4.2.1 Hydrolysis 
In the hydrolysis method, HA is obtained by the hydrolysis reaction of acid calcium-
phosphates in an aqueous system. The method may be used to purify powder, and produce 
small particle sizes [53]. Preparation of calcium-deficient or substituted apatites can also be 
accomplished by the hydrolysis of ACP, DCPD or DCPA, OCP, α- or β-TCP or tetracalcium 
phosphate, Ca4(PO4)2O, TTCP, in a solution containing OH
-
. 
 
The use of hydrolysis for the production of hydroxyapatite was first reported by Schleede et 
al. in 1932 [54]. They obtained a precipitate using either tetracalcium phosphate (Ca4(PO4)2O) 
or calcium deficient apatite (Ca9(PO4)9(HPO4)OH) at a temperature of 90°C. Young and 
Holcomb synthesised hydroxyapatite by refluxing dehydrated calcium hydrogen phosphate in 
distilled water for 1 month [53]. The reaction occurring was:  
 
5CaHPO4 + H2O → Ca5(PO4)3(OH) + 2H3PO4 
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4.2.2 Precipitation 
Precipitation occurs by nucleation and growth and is widely used to produce ceramic powders 
on both the laboratory and industrial scale [53].  
 
Among the range of precipitation routes, the two most popular are the reaction of: 
 
 1) Diammonium hydrogen phosphate with calcium nitrate 
 
 2) Orthophosphoric acid with calcium hydroxide  
 
The reaction when using diammonium hydrogen phosphate with calcium nitrate is as follows 
[55]: 
 
10Ca(NO3) 2 + 6(NH4) 2HPO4 + 8NH4OH  →  Ca10(PO4)6(OH) 2 + 20NH4NO3 + 6H20      
 
The major disadvantage of this method is that the purity of the precipitated HA powders is 
affected by the purity of the calcium nitrate. Aqueous ammonia must also be used to keep the 
pH of the reaction at around nine. The excess ammonia and ammonium by-products must be 
removed by extensive washing. The orthophosphoric acid with calcium hydroxide precipitation 
route is a more convenient process and suitable for the industrial production of HA since the 
only by-product is water. However, some researchers have found it difficult to obtain HA of 
stoichiometric composition using this method [56]. The reaction is as follows [55]: 
 
10Ca(OH)2 + 6(H3) PO4  →  Ca10(PO4)6(OH)2 + 18H2O  
 
Studies have noted that a number of factors can affect the overall characteristics of the HA 
produced. These include the reaction temperature, the reactants concentration and the rate of 
mixing reactants [55]. Because precipitated anions (PO4
3-
) are generated slowly in solutions 
containing the metal ions (Ca
2+
) it is necessary to add the phosphate solution in drops to the 
calcium ions-containing solution [56]. 
 
Secondary phases may be produced with different reaction pH values, for example in a study 
by Kweh et al. [55], traces of TCP were detected at a pH of 5 or 7 and at a pH of 11 traces of 
CaO were identified. A pH of 9 has been found to provide an appropriate environment for the 
formation of stoichiometric pure HA powders [55]. The correct temperature for the reaction 
has been found by some authors to be 40°C [56]. LeGeros [30] has reported that the 
crystallinity of precipitated apatites increases with increasing temperature of preparation. 
When precipitated at temperatures of 80 to 100°C, apatite is obtained from solution with an 
initial pH of 4 to 11; the calcium deficiency of the apatite or apatitic precipitation decreasing 
with increasing pH.  
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When prepared at temperatures, below 80°C, the pH/temperature dependence of the 
formation of different calcium phosphate phases (e.g. DCPD, DCPA, OCP) becomes evident 
unless F is present which promotes the formation of (F,OH) apatite. The reaction conditions 
and speed of drying the final precipitate can affect the size and shape of the particles.  Large 
particles have been found to result when the addition rate of acid is lowered [56]. One 
disadvantage relating to the use of wet chemical methods for HA production is that the 
powder prepared by this method is usually poorly crystallized, inhomogeneous in composition 
and irregularly formed [52]. 
 
4.3 Solid State Reactions Methods 
The solid state reaction method is a dry processing method [52]. HA can be produced by 
mixing calcium compounds and firing them at temperatures above 900°C. An example of a 
possible reaction is [21]: 
 
6CaHPO4 + 4Ca(OH)2 → Ca10(PO4)6(OH)2 + 6H2O 
 
The solid state reaction method can provide high purity products, but the process is 
chemically restricted to certain compositions, and it is difficult to obtain a precise composition. 
The resulting powders often exhibit heterogeneity in composition due to incomplete reaction 
resulting from small diffusion coefficients of ions within solids [52]. The powder particles also 
tend to have irregular forms with a large grain size. 
 
4.4 Hydrothermal Method 
Hydrothermal reactions take place in aqueous solutions under the conditions of high 
temperature and high pressure. β-TCP, Ca3(PO4)2 and tetracalcium phosphate (TTCP), 
Ca4P2O9 or Ca4(PO4)2O can easily be converted to HA hydrothermally at these conditions 
[21]. Pure HA can be obtained by carrying out a hydrothermal reaction of calcium carbonate 
CaCO3 and CaHPO4 or (NH4)2HPO4 at 275°C under steam pressure of 12,000 psi [50].  
 
The reactions following reactions can be used [21]: 
 
4CaCO3 + 6CaHPO4 → Ca10(PO4)6(OH)2 + 6H2O + 4CO2 
 
10CaCO3 + 6(NH4)2HPO4 → Ca10(PO4)6(OH)2 + 6H2O + 6CO2 
 
HA powder prepared using the hydrothermal method is well crystallized, compositionally 
homogeneous, uniform and easily sinterable due to the effects of the high temperature - high 
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pressure aqueous solutions [52]. Because of this the hydrothermal method has been 
recognised as an excellent method for the preparation of HA. 
4.5 Other Processes 
Researchers have also looked at other methods for producing synthetic hydroxyapatite. 
These methods include the melt growth method, the flux growth method and the sol-gel 
method. 
 
4.5.1 The Melt Growth Method 
The melt growth method has been used for the preparation of single crystals of apatite from a 
stoichiometric melt. However, the high temperatures conditions required usually result in 
crystals that are severely strained due to the large temperature gradients present during 
growth. 
 
4.5.2 The Flux Growth Method 
The flux growth method is similar to the melt growth method, except it involves the addition of 
materials, called fluxes. The fluxes, for example CaF2, CaCl2 and Ca(OH)2, are mixed with the 
starting apatite powders and reduce the liquidus temperature far below that needed for the 
melt growth method, resulting in the production of less strained apatite crystals.  
 
4.5.3 Sol-Gel Method 
Sol-gel processing is a chemically based method for producing ceramics, glass, glass 
ceramics and composites at much lower temperatures than the traditional processing 
methods [8]. The method involves creating a three-dimensional interconnecting network, 
termed a gel from a suspension of very small colloidal particles. Colloidal particles are solid 
particles with very small diameters, (<100nm). A liquid containing a dispersion of these 
particles is termed a sol. Once a gel is formed it is then dried to a powder. There are three 
general methods used to form sol-gel materials. These are: [8] 
 
1. Gelation of colloidal powders 
 
2. Hypercritical drying 
 
3. Controlled hydrolysis and condensation of metal alkoxide precursors followed by 
drying at ambient pressure. 
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The sol-gel process has been successfully applied in the fabrication of both irregularly shaped 
and spherical powders of calcium phosphates with various Ca/P ratios. The process has a 
number of advantages for the production of HA powders. It is a low temperature process with 
the ability to generate nanosized particles. It also has tremendous flexibility to generate 
nanocrystalline powders, bulk amorphous monolithic solids and thin films [57]. The process 
also offers a molecular-level mixing of the calcium and phosphorus precursors, which is 
capable of improving the chemical homogeneity of the resulting HA [58]. The shortcomings of 
the process are the requirement for expensive alkoxide-based precursors or the need for 
several complicated steps to ensure complete dissolution of precursors to generate phase 
pure HA after post-heat treatment [57]. 
 
Researchers have used a number of combinations of calcium and phosphorus precursors for 
sol-gel HA synthesis. Phosphorus alkoxides, mainly triethyl phosphate and triethyl phosphate, 
seem to be the most frequently used as the phosphorus precursors. The process is affected 
by differences in chemical activity of the precursors, such as hydrolysis, polycondensation 
[58]. The temperature that is required to form the apatitic structure depends largely on the 
chemical nature of the precursors.  
 
Liu et al. [58] reported on some of the synthesis methods used by other researchers. They 
found that Takahashi et al. [59] used calcium nitrate and phosphonoacetic acid 
(HOOCCH2PO(OH)2) in an aqueous solution and obtained a pure HA powder at 700°C and 
Brendel et al. [60] obtained HA at temperatures of 900°C using calcium nitrate (Ca(NO3)2 
4H2O) and phenyldichlorophosphite (C6H5PCl2) as precursors. In their own experiments, Lui 
et al. [58] produced HA at temperatures of 250°C using triethyl phosphate and calcium nitrate. 
Kim and Kumta [57] synthesized HA using Ca(NO3)24H2O and P2O5. Deptula et al. [61] 
carried out a study to produce spherical and irregularly shaped powders. They produced 
spherical powders using calcium acetate and dehydrated 2-ethyl-1-hexanol and irregular 
shaped powders were obtained when using calcium nitrate and dehydrated 2-ethyl-1-hexanol.  
 
4.6 Powder Processing 
After production of HA, processing may be necessary in order to give a powder with the 
properties required to produce the HA coating. Important morphological parameters include 
the particle size, particles shape, porosity, surface parameters, particle flowability, phase 
composition and homogeneity. Depending on the processing technique used, the powder 
may require drying after production. Methods used include atomizing, agglomeration and 
spray drying. This drying process may then be followed by other techniques, such as 
calcination, crushing, and spheroidizing, which will give the crystallinity and particle size 
required.  
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4.6.1 Atomization 
The atomization process involves introducing the material into a nozzle at high pressures. 
The material is atomized as it passes through the nozzle, resulting in a fine spray of powder 
particles that fall into the powder collector below. Either gas atomization or water atomization 
can be used. The shape of the resultant particles is dependent on the type used and is also 
influenced by the method of quenching. Gas-atomized particles are highly spherical whereas 
water-atomized particles have a more angular shape [62]. The purity of the powder is affected 
by the atmosphere inside the atomization chamber, the atomization medium and the cooling 
medium [63]. 
 
4.6.2 Agglomeration 
The agglomeration process agglomerates very fine powder particles to give an appropriate 
particle size. Powders manufactured by agglomeration of finer particles must be thoroughly 
sintered to guarantee mechanical stability. The process is carried out through a sequence of 
different steps including pelletizing, pressing or spray drying [62]. Variation of the processing 
parameters leads to large differences in powder densities and surface areas.  
 
Spray drying 
Spray drying is a commonly used method in the powder production process. The process 
combines the atomization and agglomeration methods discussed above. The first step in the 
spray drying process involves heating a gas source and introducing it into the funnel shaped 
drying chamber of the spray dryer. The liquid feed material, called a slurry, is then introduced 
into this drying chamber through separate air jets, causing it to be atomised into a fine spray 
or mist. The mist particles are then dispersed in the air within the chamber. The extent of 
atomisation and the length of the time that the particles are in contact with the hot air gas 
source influence the drying of the particles.  
 
Once mixed with air, the particles are dried and then collected. The coarse, dry particles are 
collected from the chamber collection point at the base of the drying chamber in buckets. Air 
borne particles are separated from exhaust air by cyclones. The powder collected from the 
cyclone is smaller in size than that from the chamber collection point. Powder can be 
removed from the walls of the spray dryer into the collection points by air brooms, sweepers, 
pneumatic hammers or vibrators. 
 
There are three main types of spray dryers. They can be distinguished from one another by 
their flow patterns, which can be co-current, counter current and mixed. The powder produced 
in the process is relatively porous and so densification may be required. The particle size of 
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the powder produced can range from about ten microns to a few hundred microns in size. 
Most HA powders are of the agglomerated spray dried genre.  
Calcination/ Sintering 
Calcination, or sintering, is a heat treatment that is used to increase both the crystallinity and 
the density of powder. The process also removes any binders used during spray drying. The 
increase in crystallinity is due to the growth of the fine crystallites in the agglomerated 
particles and the transformation of some amorphous phases to crystalline phases. Kweh et al. 
[55] showed that during the calcinations of HA, α-TCP begins to surface once calcination 
temperatures reach 1000C. Therefore, it is necessary to keep the calcination temperature 
below 1000C. Cheang and Khor [64] obtained good results from HA feedstock calcined at a 
temperature of 800°C for 4 hours. Kweh et al. [55] calcined HA at a temperature of 900°C for 
2 hours.  
 
Crushing 
Particles may need to be crushed in order to give the correct particle size. Ball milling and 
attrition milling, also called high energy bead milling, are the most commonly used methods. 
Ball milling uses milling pots and milling balls usually made of porcelain. The attrition mill 
consists of a chamber containing very small beads, <1mm, generally made of toughened 
zirconia. The powder is suspended in a slurry within the chamber. It is circulated by a paddle 
in order to agitate the media. Attrition milling is more effective than ball milling, resulting in 
finer particle sizes. The particles obtained from milling processes are irregularly shaped and 
subsequently have poorer flowability than spherical particles. They also have a rather broad 
particle size distribution.  
 
Spheroidization 
The spheroidization process is used to produce spherical particles. Spheroidized HA has 
been produced by Cheang and Khor [64] using the flame spraying processing, spraying the 
powder into distilled water using a combustion gun.  The resulting HA powder particles are 
highly dense spherical particles with a glassy smooth texture [64]. They have also been 
shown to have better flow properties than spray dried, calcined HA [55]. They have shown 
good results when used for the production of plasma sprayed coatings, resulting in an 
increase in deposition efficiency and decrease in coating porosity [65]. 
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5 Calcium Phosphate Coatings 
5.1 Introduction 
As discussed in Chapter 3, the brittleness of calcium phosphate ceramics, such as 
hydroxyapatite, means that they are unsuitable for use in load bearing applications. For this 
reason they are used as a coating to a tougher substrate, such as a metal alloy, e.g. steel or 
titanium. These coatings are used to encourage the ingrowth of bone material and are used 
for the fixation of dental implants and joint replacement components. 
 
5.2 Coating Application Methods 
Numerous coating techniques can be used for the application of bioceramic coatings. These 
include physical vapour deposition (PVD) techniques, chemical vapour deposition (CVD), 
electrophoretic deposition (EPD), biomimetic processes, sol-gel methods, and thermal 
spraying techniques. 
 
5.2.1 Physical Vapour Deposition (PVD) 
The physical vapour deposition technique involves bombarding a target material with a high 
energy ion beam within a vacuum. This results in atom sized particles of the material being 
sputtered onto a metallic substrate, to form a coating. Many physical vapour deposition 
techniques have been developed in recent years. These include radio frequency magnetron 
sputtering, ion beam assisted deposition (IBAD), ion beam deposition (IBD), ion beam mixing 
(IBM) and techniques that are based on plasma-assisted ion implantation, such as plasma 
source ion implantation (PSII) and plasma immersion ion implantation (PIII).  
 
5.2.2 Chemical Vapour Deposition (CVD) 
The chemical vapour deposition process involves the nucleation and growth of a coating 
through chemical reactions involved in the gases immediately above the substrate. The 
process is carried out in a vacuum, at high temperatures, usually about 1000°C. The rate of 
coating deposition can be controlled by controlling the chemical potential (concentration) of 
reaction gases.  
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5.2.3 Electrophoretic Deposition (EPD) 
The electrophoretic deposition technique involves the suspension of HA particles in 
isopropanol or other suitable organic liquid. An electric current is then passed through the 
suspension causing the migration of charged particles towards the counter charged electrode, 
resulting in deposition. The particles are deposited with minimal change to their original 
phase. The size of the particles to be deposited by the electrophoresis is particularly 
important, since the particles must be fine enough to remain in suspension during the coating 
process [66]. The rate of particle deposition and the thickness of the coating depend on the 
electric field strength [9]. The pH, ionic strength and viscosity of the solution also affect the 
properties of coating formed [67].  
 
5.2.4 Biomimetic Coatings 
Biomimetic processing is a name given to fabrication strategies that imitate natural processes, 
such as bone and dental enamel formation [12]. The process is based on the fact that when a 
scrupulously clean titanium substrate is immersed in either Hank’s balanced salt solution or 
simulated body fluid at 37°C for several days, a bone-like layer is deposited [9]. The resulting 
coatings are relatively thin, 1-5μm, and are amorphous or amorphous-crystalline structures. 
They have been shown to be biologically active, but despite this have not yet been used in 
clinical application [9].  
 
5.2.5 Sol-gel Coatings 
The sol-gel process is based on the hydrolysis and condensation of reagents that are mixed 
in solution, either as a colloidal suspension of inorganic particles, or a metal alkoxides or 
other organic precursors. The substrate is usually dipped coated by dipping it into the sol. An 
inorganic network like sponge, called a gel, then forms on the substrate, which after heating 
densifies to a solid material. The coatings are prepared at room temperature, and then fired at 
elevated temperatures in the region 400-1000°C [9]. 
 
5.2.6 Thermal Spraying 
The thermal spraying process involves passing the deposition material through a heating 
zone where it is melted. The molten particles are then propelled towards the substrate where 
they are deposited to form a coating. The history of thermal spraying dates back to the late 
1800’s. There are many different thermal spraying techniques including flame spraying, the 
spray and fuse process, high velocity oxy-fuel (HVOF) spraying, the electric arc process, the 
detonation-gun process and plasma arc spraying. Some of the advantages and 
disadvantages of the various coating techniques are discussed in table 5.1. 
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Table 5.1: Advantages and disadvantages of some coating techniques 
Method Characteristics References 
Electrophoretic Deposition Leads to impurities 
Difficult to achieve uniform thickness 
Low bond strength 
[66-69] 
Physical Vapour Deposition Inadequate deposition rate 
Resultant Ca/P ratio may be too high 
[70-74] 
Chemical Vapour Deposition Pure, highly crystalline coating can be 
produced 
High bond strength 
The maximum thickness that can be 
achieved is only 20μm 
[75] 
Thermal Spray High deposition rate 
Good chemical and microstructural 
control 
Coating thickness can easily be 
controlled 
Complex shapes can easily to coated 
[76-80] 
 
5.3 Plasma Spraying 
In this technique, a direct current arc is established between two electrodes. A stream of 
mixed gases, such as argon and nitrogen, is feed into the arc. The electrical energy causes 
atoms of the gas to be excited to high energy levels. The atoms then loose some of their 
electrons and become ionised producing a plasma. This is called a plasma arc or plasma 
flame. The plasma flame has a very high velocity and can reach temperatures of up to 
16,600°C [41]. Powder is fed into the plasma flame by a carrier gas, where it melts and is 
then accelerated towards the substrate. The molten particles hit the substrate and form the 
coating. The spraying process is shown in figure 5.1.  
 
There are many different plasma arc, or plasma spraying, processes. The different techniques 
can be distinguished according to the surrounding atmosphere during spraying. Processes 
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that use air as the spraying atmosphere include, atmospheric plasma spraying (APS), high 
power plasma spraying (HPPS) and shrouded plasma spraying (SPS). Processes which 
require special spraying atmospheres include vacuum plasma spraying (VPS), underwater 
plasma spraying (UPS) and controlled atmosphere plasma spraying (CAPS). Atmospheric 
plasma spraying and vacuum plasma spraying are the two most commonly used for the 
production of HA coatings.  
 
 
Figure 5.1: Atmospheric Plasma Spraying  
 
5.4 Coating Properties 
5.4.1 Chemical Composition 
The chemical properties of both HA powder and HA coatings are regulated by standards. 
According to the ISO standard (ISO 13779-1: 2000) [81] the atomic Ca/P ratio for HA powder 
has to be between 1.65 and 1.82. The concentration of trace elements present in the coating 
is given in the table 5.2. The maximum allowable total limit of all heavy metals that can be 
present in the coating is 50 ppm. 
 
The chemical composition of the final coating is dependent on the thermal decomposition 
occurring during spraying. The ISO standard specification (ISO 13779-2:2000) [82] states that 
coatings of HA should have a Ca/P ratio in the range of 1.67 to 1.76. The maximum allowable 
limits for trace elements are the same as that for HA powder (see table 5.2).   
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Table 5.2: Maximum allowable limits for trace elements [82] 
Elements Symbol ppm., max 
Arsenic As 3 
Cadmium Cd 5 
Mercury Hg 5 
Lead Pb 30 
 
X-ray Diffraction is one of the most important tools for determining the atomic arrangements in 
matter. It can be used to identify the phases present in samples from raw starting materials to 
finished product and to provide information on the physical state of the sample, such as grain 
size, texture and crystal perfection [83]. The technique allows rapid data acquisition, it is a 
non-destructive technique and samples are acceptable in many forms such as powder, single 
crystal, or flat polished crystalline materials. The overall size of the sample examined in a 
given experiment can be as small as 10µm
2
.  
 
In general the use of X-ray Diffraction is restricted to crystalline materials, although some 
information may be obtained on amorphous solids and liquids. It is recommended as a 
technique for the verification of the phase composition of plasma-sprayed HA coatings by the 
Food and Drug Administration (FDA) and required by ASTM F1185-88, “Standard 
Specification for Composition of Ceramic Hydroxyapatite for Surgical Implants” [84]. A sample 
XRD pattern for hydroxyapatite is shown in figure 5.2. 
 
Phase identification using XRD is based on the unique pattern produced by every crystalline 
phase. The composition of a sample can therefore be determined by comparing the diffraction 
pattern with the compilation of standard patterns that have been developed for most known 
compounds by the Joint Committee of Powder Diffraction Society, (J.C.P.D.S.). The relevant 
J.C.P.D.S. standards for Calcium Phosphate materials are listed in table 5.3 below.  
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Figure 5.2: XRD pattern for HA 
 
Table 5.3: J.C.P.D.S. standards for calcium phosphate materials 
Material Symbol Formulae 
J.C.P.D.S. 
reference 
Hydroxyapatite HA Ca10(PO4)6(OH) 9-432 
α-Tricalcium Phosphate α-TCP α-Ca3(PO4) 2 9-348 
β-Tricalcium Phosphate β-TCP β-Ca3(PO4) 2 9-169 
Tetracalcium phosphate TTCP Ca4(PO4)2O 25-1137 
Calcium Oxide CaO CaO 4-777 
Octacalcium Phosphate OCP Ca8H2 (PO4) 6.5H20 26-1056 
Dicalcium phosphate 
anhydrous 
DCPA CaHPO4 9-80 
Dicalcium phosphate 
dihydrate 
DCPD CaHPO4.2H20 9-77 
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5.4.2 Coating Crystallinity 
The coating crystallinity is determined by the degree of particle melting and the solidification 
time of the lamella. As discussed in Chapter 3, coatings that contain a high degree of 
crystallinity have lower dissolution rates and are thus more stable in vivo. Highly amorphous 
coatings dissolve quickly leading to the rapid weakening and disintegration of the coating. 
However, it has been recognised that the amorphous HA content promotes beneficial 
physiological activity. It is thus desirable for a HA coating to contain both crystalline and 
amorphous phases.  
 
The ISO standard specification (ISO 13779-1:2000) [81] states that hydroxyapatite powder 
should have a crystallinity of not less then 95%. The allowable level of other crystalline 
phases is 5% with the balance being amorphous.  
 
The ISO standard relating to HA coatings, ISO 13779-2:2000 [81], states that in order for a 
HA coating to have sufficient mechanical properties in vivo the crystalline content should be 
greater than 45%. The maximum allowable level of other phases is 5%, with the balance 
being amorphous. In general, the crystallinity of HA coatings is about 65-70% [85].  
 
5.4.3 Coating Adhesion 
Although it is well recognised that the coating adhesion is one of the most important 
parameters affecting the performance of an implant in vivo, the actually mechanisms involved 
are still not fully understood. Generally, the bottom surfaces of the lamellae are not in full 
contact with the substrate. The areas that are in contact are called the ‘welding points’ or 
‘active zones’ [63]. Clearly, the greater the contact area the better the adhesion of the coating 
will be. In the past researchers, such as Lacefield [10] believed that substrate to coating 
bonding was entirely mechanical. It is now recognised that a large number of factors are 
involved in the adhesion mechanism. The main mechanisms are mechanical anchorage, 
physical interaction and chemical interaction.  
 
Mechanical Anchorage  
Mechanical anchorage is the main mechanism involved in coating adhesion. The levels 
achieved depend on the substrate surface roughness, Ra. The adhesion strength of a ceramic 
coating is in many cases a linear function of the average surface roughness [62]. Substrate 
preparation techniques, such as grit blasting, are used to increase roughness prior to 
spraying. The amount of mechanical anchorage achieved is reduced if a large amount of 
shrinkage occurs during solidification of the particles.  
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Physical Interaction 
If there is close contact between the atoms of the lamella and the substrate, forces, known as 
Van der Waals forces, may occur between the atoms. The surfaces must be very close to 
each other to reach the field of attraction of the atoms, i.e. 0.5nm [63]. These forces 
contribute to the coating to substrate bonding. In order for them to be present, the surface 
must be clean and both materials should be in a higher energy state.  
 
Metallurgical Interaction 
There are two possible mechanisms of metallurgical interaction: diffusion and chemical 
reaction between the lamella and substrate. The diffusion occurs mainly by vacancies being 
present in high concentration in rapidly solidified lamella [63]. According to Fick’s law, 
diffusivity increases with increasing contact temperature [62]. Diffusive adhesion generally 
plays only a minor role in the overall coating adhesion as rapid cooling and solidification of the 
particles means that the diffusion depth is very small. The amount achieved can be increased 
by preheating the substrate. Chemical adhesion results when a chemical compound forms 
between the coating and substrate.  
 
According to ISO requirements (ISO 13779-2:2000) [82] the adhesion strength should be not 
less than 15MPa. Ideally, the coating adhesion strength would be as high as possible. The 
adhesion strength of a plasma sprayed HA coating on a titanium substrate is generally about 
28MPa [86]. During adhesive testing of HA coatings, failure is generally a mixture of both 
adhesive (i.e. at the implant coating-interface) and cohesive failure (i.e. occurring within the 
coating) [86-88].  
 
5.4.4 Coating Microstructure 
The microstructure of a coating greatly affects its performance in vivo. Porosity is an inherent 
characteristic of all sprayed coating. The degree of porosity depends on the properties of the 
powder particles when they impinge on the substrate surface. If the particles are highly 
molten, they can flow over the surface and fill gaps and pores. This results in a denser 
coating. Semi-molten particles give a more porous coating structure. Porosity can be 
controlled by varying the particle solidification time. This is achieved by altering spraying 
parameters, such as the temperature of the plasma flame and the level of substrate heating. 
 
Pores can also be formed due to the liberation of oxygen, nitrogen and hydrogen as the 
temperature of the material decreases and the solubility of these materials reduces 
accordingly [89]. In some cases these gases can escape to the atmosphere. Otherwise they 
remain trapped within the coating.  
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The optimal microstructure for coatings is under debate. On the one hand a dense coating is 
necessary in order to prevent coating dissolution. On the other hand porosity allows bone 
growth into the coating and results in a better bone to coating bond. A large pore size is 
necessary to allow the ingrowth of bone into HA coatings. Vascular tissue does not appear in 
pores that are less than 100μm [8]. The optimal porosity for bone ingrowth has been reported 
to be 200-400μm [90]. Pore interconnectivity is also required. The porosity of commercially 
available HA coatings may vary from 1% to 10% and sometimes may be as great as 50% 
[91].  
 
The surface roughness of the HA coating influences the ability of bone to bond to it and also 
affects its dissolution properties. A rough coating surface enhances cell adhesion and 
proliferation [92]. However, a rough coating will also have a greater surface area exposed to 
the body fluids. It will therefore dissolve more quickly. An example a typical microstructure of 
a plasma sprayed HA coating is shown in the SEM micrograph in figure 5.3. This coating was 
produced using the Sulzer Metco 9MB Plasma Spray gun in the National Centre for Plasma 
Science and Technology (NCPST) in Dublin City University. 
 
 
Figure 5.3: SEM micrograph of the microstructure of a plasma sprayed hydroxyapatite 
coating 
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5.4.5 Residual Stress 
Residual stresses are the internal stresses existing in a body that is under no external load 
condition [93]. They are generated from inhomogeneouosly distributed non-elastic changes in 
dimensions. Residual stresses are inherently induced in any coated deposited by thermal 
spray methods because of the differences in the thermal properties between the coating and 
the substrate material.  The process is also complicated by the differences between the 
thermal expansion coefficients of the various phases within the material of the coating and the 
different temperature ranges experienced by different regions of the component at different 
times during the process.  
 
The presence of residual stresses leads to crack generation and flaking or peeling of the 
coating. If spraying parameters are carefully controlled, compressive residual stresses can be 
generated which can improve the coating characteristics. This is difficult to achieve due to the 
complexity of the process.  
 
The parameters that affect residual stress generation include the plasma flame temperature, 
the sprayed particle properties, the substrate temperature and the cooling effects. The coating 
thickness also affects the residual stresses present. Adding a greater number of layers results 
in higher residual stresses. Residual stress generation can be reduced by preheating the 
substrate. The pre-heat temperature selected must be low enough so as not to adversely 
affect the substrate. Residual stress levels of 44.2MPa were reported by Yang et al. [86] and 
between about 18 and 41MPa by Tsui et al. [94].  
 
5.4.6 Coating Thickness 
The thickness of the final coating is dependent on the number of passes of the plasma gun, 
the powder feed rate and the deposition efficiency. Thick coatings have better resorption 
properties and thus provide better protection for the bone from metal-ion released from the 
substrate; however, they tend to be brittle. The presence of residual stresses in these thicker 
coatings leads to cracking. Thin coatings perform better mechanically; however, they provide 
less protection from metal-ion release and also dissolve quickly in vivo. Generally, HA 
coatings are between 50μm and 100μm in thickness [95]. The optimal coating thickness has 
been reported to be 50μm [91].  
 
5.4.7 Coating Strength 
The mechanical properties of HA coatings depend on a number of important coating 
characteristics, such as porosity, the number of defects present and the coating thickness. As 
discussed above, the strength of a coating is inversely proportional to its thickness. The 
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strength of plasma sprayed HA coatings also depends on the cohesion between the individual 
particles of the coating.  
 
The requirements for the mechanical properties of HA coatings are outlined in various 
standards. According to ISO 13779-1:2000 (Implants for Surgery – Hydroxyapatite. Part 1: 
Ceramic Hydroxyapatite) [81], the compressive strength of sintered hydroxyapatite powder 
should be not less than 1.5 MPa and the shear strength of HA coatings should be 22-29MPa. 
No criterion has been suggested for the Young’s modulus [91].  
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